Zobrazeno 1 - 10
of 265
pro vyhledávání: '"K. Brun"'
Publikováno v:
SIAM Journal on Applied Mathematics
This paper concerns the modeling and numerical simulation of the process of speciation. In particular, given conditions for which one or more speciation events within an ecosystem occur, our aim is to develop the necessary modeling and simulation too
Autor:
K Bjørlykke, M K Brun, M K Viken, G E Stenvik, R A Klaasen, J E Gehin, D J Warren, J Sexton, E A Haavardsholm, J Jahnsen, B A Lie, G L Goll, N Bolstad, S W Syversen, K K Jørgensen
Publikováno v:
Journal of Crohn's and Colitis. 16:i594-i595
Background Immunogenicity is a leading cause of treatment failure to TNF inhibitors. Genetic variations in HLA class II genes have been suggested to predispose to anti-drug antibody formation, but studies using high-resolution HLA typing as well as c
Autor:
M. K. Brun, K. H. Bjørlykke, M. K. Viken, B. Stenvik, R. A. Klaasen, J. Gehin, D. J. Warren, J. Sexton, Ø. Sandanger, C. Mørk, T. K. Kvien, E. A. Haavardsholm, J. Jahnsen, G. L. Goll, B. A. Lie, K. K. Jørgensen, N. Bolstad, S. W. Syversen
Publikováno v:
Annals of the Rheumatic Diseases. 81:216.2-217
BackgroundImmunogenicity is a leading cause of treatment failure to TNF inhibitors, and also affects drug safety. Variations in HLA class II genes have been suggested to predispose to anti-drug antibody formation (ADA), but characterisation of biolog
Autor:
Kristin K. Joergensen, Silje W Syversen, Guro L. Goll, Kristin H. Bj⊘rlykke, Øystein Sandanger, Joe Sexton, Marthe K. Brun, Cato M⊘rk, Tore K. Kvien, Johanna E. Gehin, Inge C Olsen, Nils Bolstad, Espen A. Haavardsholm, Jorgen Jahnsen
Publikováno v:
Gastroenterology. 162:S-44
Autor:
Kristin H. Bj⊘rlykke, Marthe K. Brun, Marte K. Viken, Grethe-Elisabeth Stenvik, Rolf A. Klaasen, Johanna E. Gehin, David J. Warren, Joe Sexton, Espen A. Haavardsholm, Jorgen Jahnsen, Benedicte A. Lie, Guro L. Goll, Nils Bolstad, Silje W Syversen, Kristin K. J⊘rgensen
Publikováno v:
Gastroenterology. 162:S-17
Autor:
D. Őri, P. Szocsics, T. Molnár, L. Bankovska Motlova, O. Kazakova, S. Mörkl, M. Wallies, M. Abdulhakim, S. Boivin, K. Bruna, C. Cabaços, E. A. Carbone, E. Dashi, G. Grech, S. Greguras, I. Ivanovic, K. Guevara, S. Kakar, K. Kotsis, I. M. I. Klinkby, J. Maslak, S. Matheiken, A. Mirkovic, N. Nechepurenko, A. Panayi, A. T. Pereira, E. Pomarol-Clotet, S. Raaj, P. Rus Prelog, J. Soler-Vidal, R. Strumila, F. Schuster, H. Kisand, A. Reim, G. Ahmadova, M. Vircik, H. Yilmaz Kafali, N. Grinko, Z. Győrffy, S. Rózsa
Publikováno v:
European Psychiatry, Vol 67, Pp S62-S63 (2024)
Introduction Mental health-related stigma occurs not only within the public community but is also an issue among healthcare professionals. The relationship between national culture and provider stigma remains yet to be empirically attested. Objecti
Externí odkaz:
https://doaj.org/article/47890f6524a843baaea033a81064688b
Autor:
K K Jørgensen, S W Syversen, G L Goll, K H Bjørlykke, Ø Sandanger, J Sexton, M K Brun, G Noraberg, C M Ystrøm, K A Seeberg, I M Blomgren, R Torp, C Mørk, T K Kvien, N Bolstad, E A Haavardsholm, J Jahnsen
Publikováno v:
Journal of Crohn's and Colitis. 16:i010-i010
Background Proactive therapeutic drug monitoring (TDM), individualized treatment based on scheduled assessments of serum drug levels, has been proposed to optimize efficacy and safety of infliximab and other biologic drugs. However, it is unclear whe
Autor:
David J. Warren, Silje W Syversen, K. K. Jørgensen, Nils Bolstad, C. Mørk, Joseph O. Sexton, Rolf Anton Klaasen, T.K. Kvien, M. K. Brun, Øystein Sandanger, Inge C. Olsen, G. L. Goll, Jørgen Jahnsen, J. E. Gehin, Espen A Haavardsholm
Publikováno v:
Annals of the Rheumatic Diseases. 80:185.2-185
Background:Immunogenicity is related to loss of efficacy and safety to TNFα inhibitors and is frequently observed early in the treatment course. The highest rate of anti-drug antibody (ADAb) formation has been reported for infliximab (IFX). 1 Knowle
Autor:
Silje W Syversen, G. L. Goll, Espen A Haavardsholm, K. K. Jørgensen, Inge C. Olsen, Joseph O. Sexton, T.K. Kvien, Jørgen Jahnsen, Nils Bolstad, C. Mørk, David J. Warren, M. K. Brun, J. E. Gehin, Øystein Sandanger
Publikováno v:
Annals of the Rheumatic Diseases. 79:12-12
Background:A lack or loss of response to TNFα inhibitors (TNFi) has been associated with low serum drug levels and formation of anti-drug antibodies (ADAb). Therapeutic drug monitoring (TDM), an individualised treatment strategy based on regular ass
As of 2016, supercritical CO2 (sCO2) power plant–related research activities have closed several key technology gaps to make sCO2 cycles a viable power plant option. However, significant research is still needed in the areas of cycle optimization,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf6537349564be19b83165d7b62f2115
https://doi.org/10.1016/b978-0-08-100804-1.00015-3
https://doi.org/10.1016/b978-0-08-100804-1.00015-3